Iovance Biotherapeutics, Inc. (IOVA) Stock Overview
Explore Iovance Biotherapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Iovance Biotherapeutics, Inc. (IOVA)
Key Financials
Key Financials
Market Cap
4B
P/E Ratio
-13.24
EPS (TTM)
$-0.95
ROE
-0.41%
IOVA Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Iovance Biotherapeutics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of IOVA on the NASDAQ shows an RSI of 83.40, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $0.40 for the NASDAQ listing.
Key metrics behind Iovance Biotherapeutics, Inc.'s NASDAQ-traded stock include a P/E ratio of -13.24 and a market capitalization of 4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of IOVA on the NASDAQ.